TCT

This channel contains news about the annual Transcatheter Cardiovascular Therapeutics (TCT) conference presented by the Cardiovascular Research Foundation (CRF). It includes coverage from the annual meeting and links CRF news. TCT is the premier conference for the subspecialty of interventional cardiology, including the new subspecialty areas of transcatheter structural heart procedures.ย 

Videos | Antiplatelet and Anticoagulation Therapies

Ajay J. Kirtane, M.D., associate professor of medicine at Columbia University Irving Medical Center and director of the ...

Home October 11, 2019
Home
News | Drug-Eluting Balloons

October 10, 2019 โ€” An independent analysis of Lutonix 035 drug-coated balloon (DCB) patient-level data showed no ...

Home October 10, 2019
Home
News | Hypertension

October 10. 2019 โ€” Late-breaking results from its MODERATO II double-blind, randomized study of BackBeat Cardiac ...

Home October 10, 2019
Home
Videos | Antiplatelet and Anticoagulation Therapies

Roxana Mehran, M.D., FACC, FACP, FCCP, FESC, FAHA, FSCAI, professor of medicine and director of interventional ...

Home October 10, 2019
Home
TCT 2019 Late-breaking Presentations in the main arena. The top interventional cardiology studies of 2019. #TCT #TCT19 #TCT2019
Feature | TCT

October 10, 2019 โ€” Here are the Cardiovascular Research Foundation (CRF)ย 12 late-breaking trials and 16 late-breaking ...

Home October 11, 2019
Home
Videos | Heart Valve Technology

Torsten Vahl, M.D., director of experimental and translational research, Structural Heart and Valve Center and at the ...

Home October 09, 2019
Home
Videos | Antiplatelet and Anticoagulation Therapies

American Heart Association President Robert Harrington, M.D., interventional cardiologist and the Arthur L. Bloomfield ...

Home October 08, 2019
Home
Videos | TCT

Chandan Devireddy, M.D., offers insights about what he saw as the top take aways from the 2019 Transcatheter ...

Home October 04, 2019
Home
News | Heart Valve Technology

October 4, 2019 โ€“ A new analysis of the PARTNER 3 Trial data found a modest, but significant, improvement in one-year ...

Home October 04, 2019
Home
News | Heart Failure

October 4, 2019 โ€“ Results of a new economic analysis of the COAPT Trial data found that transcatheter mitral valve ...

Home October 04, 2019
Home
News

October 4, 2019 โ€“ RenalGuard Therapy was found to be superior to the POSEIDON method in preventing contrast-induced ...

Home October 04, 2019
Home
News | Heart Valve Technology

October 3, 2019 โ€“ Five-year results from the PARTNER 2A Trial found patients with severe aortic stenosis (AS) and ...

Home October 03, 2019
Home
People watch the presentation of the five-year EXCEL Trial data by Gregg Stone, M.D., live in the Abbott booth at TCT 2019. Abbott makes the Xience stent used in the trial, which compared equally with long term surgical outcomes. #TCT2019
Feature | Cath Lab

October 3, 2019 โ€“ Five-year data from the EXCEL Trial showed patients with left main coronary disease treated with ...

Home October 03, 2019
Home
News | Heart Failure

October 3, 2019 โ€“ The three-year results from the COAPT Trial demonstrated that reducing severe secondary mitral ...

Home October 03, 2019
Home
News | Heart Valve Technology

October 2, 2019 โ€“ The first randomized trial to compare the safety and efficacy of the new Boston Scientific Acurate neo ...

Home October 02, 2019
Home
Subscribe Now